Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous SVF for Systemic Sclerosis
NCT02975960Completed
- Sponsor
- The Catholic University of Korea
- Start
- Oct 2016
- Primary completion
- Oct 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous adipose-derived stromal vascular fraction in systemic sclerosis (SSc), sponsored by The Catholic University of Korea. Primary endpoint: modified Rodnan Skin score of hands at 12 weeks. Started Oct 2016; status: completed.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT02975960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975960.